• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

EU (govt)

	Region	Brussels
	Country	Belgium
	City	n. a. Brussels
		Address record changed: 2011-11-27
Basic data	Employees	n. a.
		Record changed: 2021-01-26

Advertisement

More documents for EU (govt)

• [1] BioVersys AG. (4/14/21). "Press Release: BioVersys Receives €20 Million in EU financing to Support Development of New Antibiotics"....
• [2] CureVac N.V.. (2/12/21). "Press Release: CureVac Initiates Rolling Submission with European Medicines Agency for COVID-19 Vaccine Candidate, CVnCoV". Tübingen & Boston, MA....
• [3] BiondVax Pharmaceuticals Ltd.. (1/28/21). "Press Release: BiondVax Announces Third Quarter 2020 Financial Results & Business Update". Jerusalem....
• [4] Omnix Medical. (1/25/21). "Press Release: Omnix Medical Wins €10.8M in EIC Accelerator Funding"....
• [5] Moderna, Inc.. (1/6/21). "Press Release: European Commission Authorizes COVID-19 Vaccine Moderna in Europe". Cambridge, MA....
• [6] Tucker, Charlotte [EU Startups]. (12/30/20). "News: Danish Startup Cellugy Nabs €2.38 Million to Make Eco-friendly Packaging from Surplus Sugars"....
• [7] BioNTech SE. (12/29/20). "Press Release: Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of Comirnaty". New York, NY & Mainz....
• [8] Evaxion Biotech A/S. (12/09/20). "Press Release: EU Boosts Evaxion’s Artificial Intelligence Vaccine Research". Luxembourg & Copenhagen....
• [9] BioNTech SE. (11/11/20). "Press Release: Pfizer and BioNTech Reach an Agreement to Supply the EU with 200 Million Doses of Their BNT162b2 mRNA-based Vaccine Candidate against COVID-19". New York, NY & Mainz....
• [10] BiondVax Pharmaceuticals Ltd.. (10/23/20). "Press Release: BiondVax Announces Topline Results from Phase 3 Clinical Trial of the M-001 Universal Influenza Vaccine Candidate". Jerusalem....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.